Business · 16/03/2021Updated: 10/17/2026 · 1 min read
Bristol-Meyers Squibb Company, et al. Withdraw FDA Approval of 19 New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 19 new drug applications from multiple pharmaceutical companies, following written notifications that the drugs are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →